ARIA DIAGNOSTICS | EMBLEEMA | GRAVL

$5M Department of Defense Contract

Embleema, in partnership with GRAVL and Aria Diagnostics (ARIA), has secured a $5 million Department of Defense (DoD) contract to deploy ANTIDOT

A pioneering biosecurity platform capable of real-time global pathogen detection. This project marks a significant advancement in decentralized biosurveillance, enabling swift and coordinated responses to public health threats by linking/creating a distributed genomic network that is scalable, redundant and disaster-proof.